ATTACHMENT 3b REVISED DATA COLLECTION TOOL #1. Million Hearts Hypertension Control Champion Application Form

Similar documents
Move the Needle on Difficult Quality Measures: How Health Plans Can Control High Blood Pressure

2016 PHYSICIAN QUALITY REPORTING OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY

Alabama Department of Public Health Bureau of Health Promotion and Chronic Disease Hypertension Control Initiatives Request for Proposals FY 2018

2) The percentage of discharges for which the patient received follow-up within 7 days after

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 537 of 593

Medicare Program; Announcement of Requirements and Registration for the MIPS Mobile

Cancer Screening in Primary Care: Lessons from Community Health Centers

Medicare & Medicaid EHR Incentive Programs

HITECH Act American Recovery and Reinvestment Act (ARRA) Stimulus Package. HITECH Act Meaningful Use (MU)

Appendix 4 CMS Stage 1 Meaningful Use Requirements Summary Tables 4-1 APPENDIX 4 CMS STAGE 1 MEANINGFUL USE REQUIREMENTS SUMMARY

CMS Quality Payment Program: Performance and Reporting Requirements

Gateway to Practitioner Excellence GPE 2017 Medicaid & Medicare

Tips for PCMH Application Submission

Advancing Care Information- The New Meaningful Use September 2017

Program Overview

Meaningful Use Basics and Attestation Process Guide for Medicare and Medi-Cal. Lori Hack & Val Tuerk, Object Health

EHR Incentives. Profit by using LOGO a certified EHR. EHR vs. EMR. PQRI Incentives. Incentives available

Advancing Care Information Performance Category Fact Sheet

Shana Scott, JD, MPH, Health Systems Team Lead Tuesday, October 3, 2017

Patient Centered Medical Home 2011 Standards

Alexander Valley Healthcare Hypertension Blood Pressure Control Redwood Community Health Coalition Promising Practice

MACRA Fall into Place. By Stephanie Cecchini, CPC, CEMC, CHISP, AAPC Fellow, AAPC MACRA Prof

Annual Reporting Requirements for PCMH Recognition Overview & Table Reporting Period: 4/3/ /31/2018

Quality Measures and Federal Policy: Increasingly Important and A Work in Progress. American Health Quality Association Policy Forum Washington, D.C.

Meaningful Use: Introduction to Meaningful Use Eligible Providers

Meaningful Use May, 2012

QUALITY PAYMENT PROGRAM

Integrating Clinical Care with Community Health through New Hampshire s Million Hearts Learning Collaborative: A Population Health Case Report

Here is what we know. Here is what you can do. Here is what we are doing.

ACCOUNTABLE CARE ORGANIZATION & ALTERNATIVE PAYMENT MODEL SUMMIT

PQRS and Other Incentive Programs

The Quality Payment Program Overview Fact Sheet

Meaningful Use: Review of Changes to Objectives and Measures in Final Rule

Meaningful Use Roadmap

The Influence of Health Policy on Clinical Practice. Dr. Kim Kuebler, DNP, APRN, ANP-BC Multiple Chronic Conditions Resource Center

Sustaining a Patient Centered Medical Home Program

in partnership with EHR Meaningful Use Guide for HITECH Attestation

PROPOSED MEANINGFUL USE STAGE 2 REQUIREMENTS FOR ELIGIBLE PROVIDERS USING CERTIFIED EMR TECHNOLOGY

Maria Durham OCSQ 3/15/2011

Medicare & Medicaid EHR Incentive Programs. Stage 2 Final Rule Travis Broome AMIA

Falcon Quality Payment Program Checklist- 2017

Data Quality Improvement Plan

Eligible Professionals (EP) Meaningful Use Final Objectives and Measures for Stage 1, 2011

Alaska Medicaid Program

MIPS eligibility lookup tool (available in Spring 2018):

Legislative Update Wipfli CAH/RHC Conference

Population Health: Physician Perspective. Kallanna Manjunath MD, FAAP, CPE Medical Director AMCH DSRIP September 24, 2015

Annual Reporting Requirements for PCMH Recognition Overview & Table Reporting Period: 4/3/2017 3/31/2018

NATIONAL ASSOCIATION OF CHRONIC DISEASE DIRECTORS 2200 Century Parkway, Suite 250 Atlanta, GA

ecw and NextGen MEETING MU REQUIREMENTS

MEANINGFUL USE TRAINING SCENARIOS GUIDE

Stage 1. Meaningful Use 2014 Edition User Manual

MIPS Program: 2018 Advancing Care Information Category

CMS Incentive Programs: Timeline And Reporting Requirements. Webcast Association of Northern California Oncologists May 21, 2013

Accelerating the Impact of Performance Measures: Role of Core Measures

HITECH* Update Meaningful Use Regulations Eligible Professionals

MACRA Implementation: A Review of the Quality Payment Program

Building a Better Home: Transformation to a Patient Centered Health Home. Anna M. Gard, FNP-BC Association of Clinicians for the Underserved

CMS: NOW AND LATER. AUGUST 19, 2016 Ryan E. Spikes, RN BSN, CHTS-IM/PW, CHTS, PCMH

Promoting Interoperability Measures

Follow-up on Blood Pressure Protocols. September 20, 2017

Thought Leadership Series White Paper The Journey to Population Health and Risk

Pharmacy Quality Measures. Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2013

Prior to implementation of the episode groups for use in resource measurement under MACRA, CMS should:

Medicaid Electronic Health Records Meaningful Use. Lisa Reuland, Program Manager October 15, 2015

10/10/2017. Mythbusters: Primary Care Edition (Expanding Opportunities) Amina Abubakar, PharmD, AAHIVP Olivia bentley, PharmD, CFts, AAHIVP

Agenda 2. EHR Incentive Programs 3/5/2015. Overview EHR incentive programs Meaningful Use Differences between Stage 1 and Stage 2

Using Data for Quality Improvement in a Clinical Setting. Wadia Wade Hanna MD, MPH Technical Assistance Consultant Georgia Health Policy Center

Meaningful Use Hello Health v7 Guide for Eligible Professionals. Stage 1

Leveraging Clinical Data for Public Health and Hypertension Surveillance

NCQA s Patient-Centered Medical Home (PCMH) 2011 Standards 11/21/11

Measure #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

Note: Accredited is the highest rating an exchange product can have for 2015.

Preparing for the 2018 EHR Medicaid Incentive Payment Program

Copyright. Last updated: September 28, 2017 MicroMD EMR Objective Measure Calculations Manual: Performance Year 2017

Population Health: The Role of the Centers for Disease Control and Prevention

SIM Cohort 3 Application Instructions and Questions

Session 10: Integrating Data and Analytics into Provider Workflows Improves ACO Quality and Financial Performance

Provide an understanding of what comprises "meaningful use" of EHR technology

MACRA Open Call December 5 th, 2016

MACRA, MIPS, and APMs What to Expect from all these Acronyms?!

MIPS Advancing Care Information: Tips, Tools and Support Q&A from Live Webinar March 29, 2017

2018 IHCP 1 st Quarter Workshop

Managing Patients with Multiple Chronic Conditions

Small Rural Hospital Transitions (SRHT) Project. Rural Relevant Measures: Next Steps for the Future

WELCOME. Kate Gainer, PharmD Executive Vice President and CEO Iowa Pharmacy Association

Friday Health Plans of Colorado

Meaningful Use Stage 2

9/28/2011. Learning Agenda. Meaningful Use and why it s here. Meaningful Use Rules of Participation. Categories, Objectives and Thresholds

Russell B Leftwich, MD

MEANINGFUL USE STAGE 2

Physician Quality Reporting System & VBPM, 2015

Evaluation of the West Virginia Cardiovascular Health Program (CVHP)

2017/2018. KPN Health, Inc. Quality Payment Program Solutions Guide. KPN Health, Inc. A CMS Qualified Clinical Data Registry (QCDR) KPN Health, Inc.

Blood Pressure Control: Path to the Million Hearts Award. Jessicca Moore, MSN, FNP Associate Clinical Director Nurit Licht, MD, Chief Medical Officer

Meaningful Use: Is Your Practice Ready? E L I Z A B E T H W O O D C O C K

Legal Issues in Medicare/Medicaid Incentive Programss

Measures Reporting for Eligible Hospitals

Unique Billing for PCMH Transition of Care/HCC Risk Management

Updated 2017 Medicaid EHR Incentive Program Requirements For Eligible Providers (EP)

Transcription:

ATTACHMENT 3b REVISED DATA COLLECTION TOOL #1 Million Hearts Hypertension Control Champion Application Form 0920-0976

Form Approved OMB No. 0920-0976 Exp. date 12/31/2019 Million Hearts Hypertension Control Champion Application Public reporting burden of this collection of information is estimated at 30 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Review Office, 1600 Clifton Road, NE, MS D-74, Atlanta, GA 30333, ATTN: PRA 0920-0976. Applicant information: Please provide the following information for the provider or practice being entered into the Challenge. Apply as either practice or provider, but not both. Practice Name (if the practice is the applicant): Provider Name (if the provider is the applicant): Business Address: City: State: Zip Code: Business Phone: Business E-mail: [1]

Check the box which best represents the applicant: A healthcare system A single clinician or group practice or clinic Check the box which best represents the applicant s practice: Obstetrics/gynecology Family practice Internal medicine Osteopathy Cardiovascular care Other Contact information (for individual submitting the application): Name: Business Address: City: State: Zip Code: Business Phone: Business E-mail: Check the box which represents your relationship with the applicant: I am the applicant Employee of the applicant Contract with the applicant State health department Other Population served Number of patients enrolled in the practice or health system: Describe patient demographics that support the practice or health system s care for a population with a high prevalence of hypertension:

Form Approved OMB No. 0920-0976 Exp. date 12/31/2019 Geographic location of clinic (select both if you are a health system and both apply): Rural Urban Percent of patients who belong to a racial/ethnic minority: Percent of patients whose primary language is not English: Percent of patients who are enrolled in Medicaid: Percent of patients who have no health insurance: Other Of the number of number of patients enrolled in the practice or health system, how many adult patients (18 85 years old) were seen at least once during the reporting period? Of this number of patients seen, distribute them by age: Percent of patients: Age: 18-44 Percent of patients: Age 45-64: Percent of patients: Age 65-74: Percent of patients: Age 75-85: Of the number of adult patients (18-85 years old) seen during the reporting period, what was the prevalence of hypertension? Report this as a percent. Hypertension Control Nominees are asked to provide two hypertension control rates: a current rate for a 12-month period and a previous rate for a 12-month period a year or more before. CDC supports the definition of hypertension control as patients aged 18 through 85 years who had a diagnosis of hypertension and whose blood pressure was adequately controlled ( <140 mmhg systolic and <90 mmhg diastolic). For the current Hypertension Control Rate: What is the reporting period (e.g., 1/1/2017 to 12/31/2017)?. [1]

For the current reporting period, the nominee used which of the following clinical quality measure to define hypertension control. Please check the appropriate box below and provide the requested information: National Quality Forum (NQF) 0018 guidelines Describe the exclusions the nominee includes (e.g., pregnant women, patients with end-stage renal disease). CMS Physician Quality Reporting System (PQRS) 236 guidelines. Describe the exclusions the nominee includes (e.g., pregnant women, patients with end-stage renal disease). CMS 165v3 guidelines. Describe the exclusions the nominee includes (e.g., pregnant women, patients with end-stage renal disease). NCQA HealthCare Effectiveness Information Set (HEDIS). Describe the exclusions the nominee includes (e.g., pregnant women, patients with end-stage renal disease). HRSA Uniform Data System (UDS). Describe the exclusions the nominee includes (e.g., pregnant women, patients with end-stage renal disease). Other. Describe how the nominee calculates the measure; including who is included in the denominator and what is considered adequate control. Calculation of Hypertension Control Rate Of the number of adult patients (18-85 years old) seen during the reporting period, how many were diagnosed with hypertension? Of the number of adult patients (18-85 years old) diagnosed with hypertension, how many are included in the control rate denominator (after removing the exclusions listed above; e.g., pregnant women, patients with end-stage renal disease)? How many of the patients were excluded from the denominator? How many of the patients in the denominator had their blood pressure in control (numerator)? [2]

What was the Hypertension Control Rate for the practice or healthcare system s adult hypertensive population during this reporting period (numerator/denominator)? For the previous period Hypertension Control Rate: For the previous reporting period, did the nominee use the same clinical quality measure guidelines as the current reporting period? Yes. No. If not, which clinical quality measure guideline was used? Using the same steps, what was the Hypertension Control Rate for the practice or healthcare system s adult hypertensive population during previous reporting period? What was the previous reporting period (e.g., 1/1/2016 to 12/31/2016): Additional Information Were the data obtained from an electronic health record system?. If not, how were the data obtained? For the current reporting period, were you participating in any of the following programs? Medicare Shared Savings Program Pioneer ACO Federally Qualified Health Center provider Indian Health Service provider CMS Million Hearts Risk Reduction Model EvidenceNOW participant Transforming Clinical Practice Initiative participant QIO/QIN participant Health Department Lead QI initiative participant Comprehensive Primary Care Plus (CPC+) practice WISEWOMAN program participant AMGF MUPD participant* Medicare Shared Savings Program Other: [3]

*American Medical Group Foundation Measure Up Pressure Down Clinical system supports Please check the button before each sustainable process for providing care in the clinic or healthcare system that is used on a regular basis. Provide a brief description of as many other processes or systems as applicable to your practice or health system. You may also add details to many of the systems described below to support the nomination. Written treatment protocols Electronic Medical Records (EMR): Registry features Electronic Medical Records (EMR): With clinical decision supports Electronic Medical Records (EMR): With e-prescribing Electronic Medical Records (EMR): With treatment/testing reminders Electronic Medical Records (EMR): With patient summary reports Team Based Care: Nurse engagement Team Based Care: Nurse Practitioner engagement Team Based Care: Pharmacist engagement Team Based Care: Patient Navigator/Care Coordinator Team Based Care: Other Provider Incentives: Financial Provider Incentives: Administrative Provider Incentives: Recognition Provider Incentives: Other [4]

Patient Incentives Non-electronic reminders or alerts for providers or patients Free blood pressure checks Provider Dashboards Please describe: Home blood pressure monitoring support or equipment Please describe: Medication adherence strategies Outreach to patients Other Is there anything else you would like to add to support the nomination? Agreement to Participate [5]

Please enter your name below to indicate that you, as the nominee, agree to the following: If you are not the nominee, please enter your name below assuring that you have consulted with the nominee, and the nominee agrees to the following: All information provided is true and accurate to the best of your knowledge. To participate in a data verification process if selected as a candidate for champion. Consent to a background check if selected as a candidate for champion. To be recognized by provider or practice name and location if selected as a champion, to participate in recognition activities, and to share best practices for the development of publically available resources. To assume any and all risks and waive claims against the Federal Government and its related entities, except in the case of willful misconduct, for any injury, death, damage, or loss of property, revenue, or profits, whether direct, indirect, or consequential, arising from my participation in this prize contest, whether the injury, death, damage, or loss arises through negligence or otherwise. To indemnify the Federal Government against third party claims for damages arising from or related to competition activities. To complete, without revisions, a required Business Associate Agreement form and/or other forms that may be required by applicable law. Thank you for participating. Submit Nomination [6]